These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
160 related items for PubMed ID: 9776305
21. Thromboxane A2-mediated shape change: independent of Gq-phospholipase C--Ca2+ pathway in rabbit platelets. Ohkubo S, Nakahata N, Ohizumi Y. Br J Pharmacol; 1996 Mar; 117(6):1095-104. PubMed ID: 8882602 [Abstract] [Full Text] [Related]
22. Activation of rabbit platelets by Ca2+ influx and thromboxane A2 release in an external Ca(2+)-dependent manner by zooxanthellatoxin-A, a novel polyol. Rho MC, Nakahata N, Nakamura H, Murai A, Ohizumi Y. Br J Pharmacol; 1995 Jun; 115(3):433-40. PubMed ID: 7582454 [Abstract] [Full Text] [Related]
23. Inhibition of [3H]platelet activating factor (PAF) binding by Zn2+: a possible explanation for its specific PAF antiaggregating effects in human platelets. Nunez D, Kumar R, Hanahan DJ. Arch Biochem Biophys; 1989 Aug 01; 272(2):466-75. PubMed ID: 2502069 [Abstract] [Full Text] [Related]
24. Antiplatelet action of 3',4'-diisovalerylkhellactone diester purified from Peucedanum japonicum Thunb. Hsiao G, Ko FN, Jong TT, Teng CM. Biol Pharm Bull; 1998 Jul 01; 21(7):688-92. PubMed ID: 9703250 [Abstract] [Full Text] [Related]
25. Antiplatelet activity of [5-(2-methoxy-5-chlorophenyl)furan-2-ylcarbonyl]guanidine (KR-32570), a novel sodium/hydrogen exchanger-1 and its mechanism of action. Lee KS, Park JW, Jin YR, Jung IS, Cho MR, Yi KY, Yoo SE, Chung HJ, Yun YP, Park TK, Shin HS. Arch Pharm Res; 2006 May 01; 29(5):375-83. PubMed ID: 16756082 [Abstract] [Full Text] [Related]
26. Dicentrine, a novel antiplatelet agent inhibiting thromboxane formation and increasing the cyclic AMP level of rabbit platelets. Yu SM, Chen CC, Ko FN, Huang YL, Huang TF, Teng CM. Biochem Pharmacol; 1992 Jan 22; 43(2):323-9. PubMed ID: 1310852 [Abstract] [Full Text] [Related]
27. Regulation of human platelet activation--analysis of cyclooxygenase and cyclic AMP-dependent pathways. Krishnamurthi S, Westwick J, Kakkar VV. Biochem Pharmacol; 1984 Oct 01; 33(19):3025-35. PubMed ID: 6091666 [Abstract] [Full Text] [Related]
28. Pharmacological characterization of cinnamophilin, a novel dual inhibitor of thromboxane synthase and thromboxane A2 receptor. Yu SM, Wu TS, Teng CM. Br J Pharmacol; 1994 Mar 01; 111(3):906-12. PubMed ID: 8019768 [Abstract] [Full Text] [Related]
29. Selective inhibition of protein kinase C. Effect on platelet-activating-factor-induced platelet functional responses. Murphy CT, Westwick J. Biochem J; 1992 Apr 01; 283 ( Pt 1)(Pt 1):159-64. PubMed ID: 1567363 [Abstract] [Full Text] [Related]
30. Anti-thrombotic and anti-inflammatory activities of protopine. Saeed SA, Gilani AH, Majoo RU, Shah BH. Pharmacol Res; 1997 Jul 01; 36(1):1-7. PubMed ID: 9368908 [Abstract] [Full Text] [Related]
31. In vitro adrenaline and collagen-induced mobilization of platelet calcium and its inhibition by naftopidil, doxazosin and nifedipine. Alarayyed NA, Cooper MB, Prichard BN, Betteridge DJ, Smith CC. Br J Clin Pharmacol; 1997 Apr 01; 43(4):415-20. PubMed ID: 9146854 [Abstract] [Full Text] [Related]
32. Dual effects of nimesulide, a COX-2 inhibitor, in human platelets. Saeed SA, Afzal MN, Shah BH. Life Sci; 1998 Apr 01; 63(20):1835-41. PubMed ID: 9820127 [Abstract] [Full Text] [Related]
33. Inhibition of cyclooxygenase activity and increase in platelet cyclic AMP by girinimbine, isolated from Murraya euchrestifolia. Ko FN, Lee YS, Wu TS, Teng CM. Biochem Pharmacol; 1994 Jul 19; 48(2):353-60. PubMed ID: 8053931 [Abstract] [Full Text] [Related]
34. Antiplatelet activity of carnosol is mediated by the inhibition of TXA2 receptor and cytosolic calcium mobilization. Lee JJ, Jin YR, Lim Y, Hong JT, Kim TJ, Chung JH, Yun YP. Vascul Pharmacol; 2006 Sep 19; 45(3):148-53. PubMed ID: 16916624 [Abstract] [Full Text] [Related]
35. Effect of phorbol 12-myristate 13-acetate on collagen-induced signal transduction in rabbit platelet. Sato T, Akiba S, Fujii T. Thromb Res; 1988 Mar 15; 49(6):567-79. PubMed ID: 3133818 [Abstract] [Full Text] [Related]
36. 1-O-hexadecyl-2-metoxy-glycero-3-phosphatidylcholine--a methoxy ether lipid inhibiting platelet activating factor-induced platelet aggregation and neutrophil oxidative metabolism. Le Blanc K, Samuelsson J, Brohult J, Berg A, Palmblad J. Biochem Pharmacol; 1995 May 26; 49(11):1577-82. PubMed ID: 7786298 [Abstract] [Full Text] [Related]
37. Comparison of the actions of some platelet-activating factor antagonists on platelets and aortic smooth muscles. Teng CM, Yu SM, Ko FN, Chen CC, Wang WC, Chen KY, Huang YL, Huang TF. Eur J Pharmacol; 1991 Nov 26; 205(2):151-6. PubMed ID: 1812005 [Abstract] [Full Text] [Related]
38. Difference of (Ca2+)i movements in platelets stimulated by thrombin and TRAP: the involvement of alpha(IIb)beta3-mediated TXA2 synthesis. Aoki T, Tomiyama Y, Honda S, Senzaki K, Tanaka A, Okubo M, Takahashi F, Takasugi H, Seki J. Thromb Haemost; 1998 Jun 26; 79(6):1184-90. PubMed ID: 9657446 [Abstract] [Full Text] [Related]
39. Effects of dilazep on cytoplasmic calcium ion concentrations and arachidonic acid metabolism in activated human platelets. Okuma M, Kanaji K, Sensaki S, Uchino H. Arzneimittelforschung; 1989 Mar 26; 39(3):372-5. PubMed ID: 2502990 [Abstract] [Full Text] [Related]
40. Effects of ethanol on pathways of platelet aggregation in vitro. Rand ML, Packham MA, Kinlough-Rathbone RL, Fraser Mustard J. Thromb Haemost; 1988 Jun 16; 59(3):383-7. PubMed ID: 3142075 [Abstract] [Full Text] [Related] Page: [Previous] [Next] [New Search]